Charlotte's Web Holdings Inc
Charlotte's Web Holdings Inc develops and commercializes hemp-based pharmaceutical and consumer products, targeting chronic pain, inflammation, and other medical conditions.
Business. Charlotte's Web Holdings Inc (CWEB.TO) is a pharmaceutical company engaged in the research, development, and commercialization of cannabis-based products. The firm is headquartered in Canada and is primarily listed on the Toronto Stock Exchange. As specific operating segment and geographic data are not provided, the company is described at the industry level within the Healthcare sector.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Charlotte's Web Holdings Inc (CWEB.TO) is a pharmaceutical company engaged in the research, development, and commercialization of cannabis-based products. The firm is headquartered in Canada and is primarily listed on the Toronto Stock Exchange. As specific operating segment and geographic data are not provided, the company is described at the industry level within the Healthcare sector.
Charlotte's Web Holdings Inc operates with a debt-to-equity ratio of 0.92 and a current ratio of 3.48, indicating a moderate liquidity position with sufficient short-term assets to cover liabilities. However, the company's operating cash flow is negative at -7.18 million USD, and free cash flow is also negative at -9.20 million USD, signaling potential challenges in generating positive cash from operations.
Profitability metrics show a return on equity of -20.64% and a return on assets of -6.8%, both significantly below industry norms for pharmaceutical firms, which typically exhibit positive returns. The company reported a net loss of 9.63 million USD and an operating loss of 8.37 million USD, highlighting a lack of profitability.
The company's revenue is concentrated in a single business segment focused on hemp-based pharmaceuticals and consumer products, with no disclosed geographic diversification. This concentration increases exposure to regulatory and market risks in the cannabis industry.
Looking ahead, the company is projected to see a decline in revenue, with a negative outlook for the current fiscal year. Historical revenue data shows a decrease from 12.12 million USD in the latest period, and no significant growth drivers are currently evident.
The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could constrain its ability to fund operations without external financing.
Recent filings and transcripts have not disclosed any major strategic shifts or new product launches. The company continues to focus on its core hemp-based product line, with no indication of diversification or expansion into new markets.
- The company has a negative return on equity and return on assets, indicating poor profitability.
- Liquidity is moderate, with a current ratio of 3.48, but operating and free cash flows are negative.
- Revenue is concentrated in a single business segment, increasing exposure to market and regulatory risks.
- The company is projected to see a decline in revenue, with no significant growth drivers identified.
- Liquidity risk is medium, and dilution risk is low, but the company's net cash position is negative after accounting for total debt.
Bull / Bear case
Generated · model-assistedOperating income improved 36.6% year-over-year, signaling a meaningful reduction in operational losses for the fiscal year.
Free cash flow improved by 11.3% year-over-year, indicating a slight stabilization in cash burn rates.
Dilution risk is assessed as low, suggesting limited immediate threat to shareholder equity from share issuance.
Credit risk is rated low, implying manageable default probabilities despite the company's ongoing financial challenges.
Revenue remained relatively stable with only a 0.5% year-over-year change, showing some top-line resilience.
The company posted a net loss of $29.7 million in the latest fiscal year, continuing its unprofitable trajectory.
Debt-to-equity ratio of 0.92 places the company in the bottom quartile of its peer group.
Liquidity risk is assessed as medium, raising concerns about the company's ability to meet short-term obligations.
In focus — financials by report
Revenue $13.3M, +5,2% YoY; Operating income −2,6% YoY.
- ▍Revenue $13.3M, +5,2% YoY
- ▍Operating income −2,6% YoY
- ▍Net income −239,2% YoY
- ▍Free cash flow −766,2% YoY
- ▍Net margin -85.7%
Revenue $12.7M; Operating income -$5.5M.
- ▍Revenue $12.7M
- ▍Operating income -$5.5M
- ▍Net margin -26.6%
Revenue $12.6M; Operating income -$6.0M.
- ▍Revenue $12.6M
- ▍Operating income -$6.0M
- ▍Net margin -46.0%
Revenue $12.3M; Operating income -$12.1M.
- ▍Revenue $12.3M
- ▍Operating income -$12.1M
- ▍Net margin -90.0%
Revenue $12.1M; Operating income -$8.4M.
- ▍Revenue $12.1M
- ▍Operating income -$8.4M
- ▍Net margin -79.5%
Revenue $49.9M, +0,5% YoY; Operating income +36,6% YoY.
- ▍Revenue $49.9M, +0,5% YoY
- ▍Operating income +36,6% YoY
- ▍Net income +0,3% YoY
- ▍Free cash flow +11,3% YoY
- ▍Net margin -59.6%
Revenue $49.7M, −21,4% YoY; Operating income +21,2% YoY.
- ▍Revenue $49.7M, −21,4% YoY
- ▍Operating income +21,2% YoY
- ▍Net income −25,4% YoY
- ▍Free cash flow −36,2% YoY
- ▍Net margin -60.1%
Revenue $63.2M, −14,8% YoY; Operating income +22,6% YoY.
- ▍Revenue $63.2M, −14,8% YoY
- ▍Operating income +22,6% YoY
- ▍Net income +59,9% YoY
- ▍Free cash flow +58,6% YoY
- ▍Net margin -37.7%
Revenue $74.1M, −22,9% YoY; Operating income +64,3% YoY.
- ▍Revenue $74.1M, −22,9% YoY
- ▍Operating income +64,3% YoY
- ▍Net income +56,9% YoY
- ▍Free cash flow +60,4% YoY
- ▍Net margin -80.0%
Revenue $96.1M; Operating income -$147.1M.
- ▍Revenue $96.1M
- ▍Operating income -$147.1M
- ▍Net margin -143.3%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Charlotte's Web Holdings Inc Market data — financials · 2026-05-27
- Charlotte's Web Holdings Inc Market data — analyst estimates · 2026-05-27